Navigation Links
New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Date:10/16/2007

th C.E.R.A. in patients (pts) with chronic kidney

disease (CKD) is unaffected by baseline hemoglobin (Hb) level. R.

Provenzano et al. (SU-PO796. November 4: 10:00 a.m. - 12:00 p.m. PST.

Exhibit Hall, Moscone Center)

-- Median hemoglobin (Hb) decline following C.E.R.A. dose interruption is

similar to that with other erythropoiesis stimulating agents (ESAs). P.

Barany et al. (SU-PO795. November 4: 10:00 a.m. - 12:00 p.m. PST.

Exhibit Hall, Moscone Center)

-- Diabetes status and ethnicity do not alter efficacy of C.E.R.A. in

patients with chronic kidney disease: analysis of 3 phase III trials.

T. Golper et al. (SU-PO1019. November 4: 10:00 a.m. - 12:00 p.m. PST.

Exhibit Hall, Moscone Center)

-- C.E.R.A. maintains hemoglobin in dialysis patients directly switched

from epoetin (EPO) without increasing iron therapy requirements. A.

Nissenson et al. (F-PO855. November 2: 10:00 a.m. - 12:00 p.m. PDT.

Exhibit Hall, Moscone Center)

-- C.E.R.A. every 2 or 4 weeks maintains hemoglobin control in CKD

patients on dialysis with and without congestive heart failure: pooled

Phase III analysis. S. Fishbane et al. (F-PO843. November 2:

10:00 a.m. - 12:00 p.m. PDT. Exhibit Hall, Moscone Center)

About MIRCERA

The clinical program for MIRCERA consisted of 10 global studies involving more than 2,700 patients from 29 countries. The Phase III program for MIRCERA included two correction studies and four maintenance studies exploring intravenous (IV) and subcutaneous (SC) MIRCERA at extended administration intervals.

MIRCERA has a longer half-life than any commercially available erythropoiesis-stimulating agent (ESA). In clinical trials MIRCERA corrected anemia in chronic kidney disease (CKD) patients with dosing once every two weeks and maintained hemoglobin levels in CKD patients with dosing intervals up to once
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
9. AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical Pipeline to Be Featured at AACR
10. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
11. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... Nov. 28, 2014 /CNW Telbec/ - Ergoresearch Ltd « Ergoresearch ... of Mrs. Dominique Boudreau who will hold ... Mrs. Dominique Boudreau was acting as corporate ... similar duties for more than seven years for Laboratoire ... January 2013.  Mrs. Boudreau replaces Mr. Greco who was ...
(Date:11/28/2014)... Kan. , Nov. 28, 2014 Aratana ... company focused on the licensing or acquisition, development and ... other companion animals, today announced that it will present ... Conference, to be held December 2-3, 2014, at the ... . Steven St. Peter , ...
(Date:11/28/2014)... 28, 2014 Alimera Sciences, Inc. (NASDAQ: ... that specializes in the research, development and commercialization ... Securities Purchase Agreement with Deerfield Management and certain ... will issue shares of preferred stock to Deerfield ... million upon the satisfaction of certain closing conditions. ...
Breaking Medicine Technology:Ergoresearch announces the appointment of its new Vice Président Finance 2Ergoresearch announces the appointment of its new Vice Président Finance 3Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3
... 5, 2011 Mylan Inc. (Nasdaq: MYL ) today ... of the NASDAQ OMX Group Inc. (Nasdaq: NDAQ ), ... due 2012 from the Nasdaq Capital Market, on which the notes ... of trading on January 28, 2011. The notes will continue to ...
... and older falls every 2.3 seconds in the U.S., and according ... cause of fatal injury in this age group. They are ... for trauma.  The growing ranks of Americans 65 and older - ... 2050 - have inspired a new technology solution that allows the ...
Cached Medicine Technology:Mylan Announces Voluntary De-listing of 1.25% Senior Convertible Notes Due 2012 from Nasdaq 2SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011 2SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011 3
(Date:11/28/2014)... Miami's Plastic Surgery of the Face recently introduced ... Jeffrey Epstein is excited to offer patients the ... the site is uniquely designed for easing viewing on ... of all prospective rhinoplasty patients research upcoming procedures online. ... with smartphones, tablets, and laptops, as well as the ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Written and narrated ... Brook Forest Voices releases the “The Happiest Man In ... a compelling account of how and why Project C.U.R.E. came ... by his mother Josie and the Reverend Richard W. Jackson, ... the age of 30, but realized that he wasn’t happy. ...
(Date:11/28/2014)... Not only is the Éminence Organic ... petroleum, parabens and other cancer-causing agents, but they are ... and awareness programs that help in the fight against ... raised an incredible, record-breaking contribution of $30,000 through participation ... the Sweet Red Rose Whip Moisturizer and the company’s ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Mabel’s ... stuff kids lose® and an award-winning company established by ... Ellis, Cynthia Esp, and Tricia Mumby have been honored ... were recognized with the PROFIT Award for Excellence in ... Cynthia Esp, and Tricia Mumby) accepted the award on ...
(Date:11/28/2014)... Lice Troopers Lice Removal Service is pleased to ... lice service for moms in Miami-Dade County. Lice Troopers is ... on Pone De-leon Blvd in Miami. The company currently ... Miami-Dade & Broward. Lice Troopers is the only Lice Clinic ... been treating families for several years. , Lice Troopers estimate ...
Breaking Medicine News(10 mins):Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2
... ... for dentists with advanced clinical training announced. , ... Seattle, WA (PRWEB) June 23, 2009 -- Big Case Marketing, the global ... for large cases and Dental Idea Lab, a Boston based coaching and consulting firm for ...
... ... and FIND (Foundation for Innovative New Diagnostics), a Swiss foundation that develops, evaluates and ... price reduction in the cost of liquid culture testing for TB (Tuberculosis). , ... Oxford, UK and Geneva, ...
... SAN DIEGO, June 22 CetylMax, LLC and Flexadren, ... Cetylated Fatty Acids (CFA,s) products aiding in joint support ... Board: IAGX), the manufacturer of Celadrin, did not prevail ... the nature and outcome of the Federal litigation between ...
... inhibitor of tumor metastasis made by tumor cells, one that ... were published in the online Early Edition of the ... week of June 22. Metastasisthe migration of cancer ... leading causes of death from cancer, and there is no ...
... WASHINGTON, June 22 The Lupus Foundation of America ... studies on lupus, an unpredictable and potentially fatal autoimmune ... lupus and adult stem cell transplantation. The purposes of ... research in humans as a treatment for lupus and ...
... , , Personalized Medicine Meeting Elicits Varying Perspectives ... Drug Administration,s (FDA,s) ability to regulate genetic testing is problematic, ... , Three-quarters of the attendees at a colloquium ... Institute (FDLI) and the American Association for the Advancement of ...
Cached Medicine News:Health News:One of a Kind Marketing and Sales Summit for Dentists Announced 2Health News:One of a Kind Marketing and Sales Summit for Dentists Announced 3Health News:BD and FIND Achieve Milestone in Global Battle Against MDR-TB 2Health News:BD and FIND Achieve Milestone in Global Battle Against MDR-TB 3Health News:BD and FIND Achieve Milestone in Global Battle Against MDR-TB 4Health News:CetylMax(R) and Flexadren(R) Win Federal Lawsuit - Court Rules Against Imagenetix 2Health News:CetylMax(R) and Flexadren(R) Win Federal Lawsuit - Court Rules Against Imagenetix 3Health News:Potent metastasis inhibitor identified 2Health News:Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 3
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
... Diameter; 5.4 Fr Straight Channel; 33 or ... MRO-7 Integral Operating Ureteroscopes offer a small ... easy access to the ureter for diagnosis ... Fr) is ideal for large operating instruments, ...
Semi-Rigid Ureteroscope...
... ACMI DUR-8 Elite's 8.7 Fr shaft reaches ... comparable scope providing complete intrarenal access, ... smooth, lubricious outer covering and working channel ... And its patented torque-stable shaft construction, tight-bend ...
Medicine Products: